SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA

Benzinga · -